Ideal Site Selection To Support Patient Recruitment For Personalized Medicine Oncology Studies

By Clare Wareing, PhD, Chief Development Officer, Chiltern

Cancer numbers are rising. According to the World Health Organization, around 14 million people were diagnosed with cancer in 2012, and this is predicted to grow to 19 million by 2025, and to 24 million by 2035. This is increasing the need for safe, efficacious and cost-effective forms of treatment. One solution is to create targeted therapeutics tailored to treat cancer with precise genetic mutations, either inherited or acquired. These are often described as personalized or precision medicines, and should have a higher efficacy rate in the specific patient subgroups.